Christer Einvik

Tromso, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A gene-specific RNA enrichment protocol for nanopore direct-RNA sequencing.

A gene-specific RNA enrichment protocol for nanopore direct-RNA sequencing.

Journal: PloS one

Published: May 28, 2025

Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cells.

Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cells.

Journal: Frontiers in pediatrics

Published: November 15, 2022

Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors.

Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors.

Journal: Frontiers in oncology

Published: October 28, 2021

Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma.

Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma.

Journal: Cancer informatics

Published: November 01, 2018

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma.

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma.

Journal: Oncogene

Published: April 26, 2018

Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells.

Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells.

Journal: Oncology letters

Published: November 02, 2017

MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN.

MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN.

Journal: Oncotarget

Published: October 26, 2016

Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.

Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.

Journal: Cancer letters

Published: September 10, 2015

Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.

Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.

Journal: Anticancer research

Published: May 13, 2015

Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.

Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.

Journal: Nature communications

Published: January 18, 2015

MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells.

MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 05, 2013

N-myc and noncoding RNAs in neuroblastoma.

N-myc and noncoding RNAs in neuroblastoma.

Journal: Molecular cancer research : MCR

Published: September 01, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026